Drug intelligence / Profile preview

policresulen

Development stage
Unknown
Lead developer
Takeda
Modality
Classical Binding Small Molecules → Small Molecules
Administration
Topical, Vaginal, Rectal
01

Overview

Policresulen is a synthetic polymolecular organic acid produced by the condensation of meta-cresolsulfonic acid and formaldehyde. It acts as a topical hemostatic and antiseptic agent primarily used for the treatment of gynecological infections (such as cervicitis and vaginitis), anal disorders (including hemorrhoids), ulcers of the oral cavity (like canker sores), and other mucous membrane lesions[1][5][7]. Policresulen exerts its effects through selective coagulation of necrotic or pathologically altered tissues while sparing healthy tissue, promoting rapid reepithelialization. Its mechanism includes chemical debridement via denaturation of cellular proteins in devitalized cells, hemostasis by coagulating blood proteins and inducing vasoconstriction in small blood vessels, and broad-spectrum antimicrobial activity against gram-positive bacteria (e.g., staphylococcus spp., streptococcus spp.), gram-negative bacteria, fungi (notably Candida albicans), protozoa such as Trichomonas vaginalis, with minimal effect on normal lactobacillus flora[3][5][6][7]. Policresulen also has anti-inflammatory and astringent properties[8].

Brand names
AlbothylPolilenNegatolFaktu
Other names
metacresolsulphonic acid-formaldehyde
02

Targets

Necrotic and pathologically altered tissue proteins and plasma membrane phospholipidsNS2B/NS3 protease (Dengue virus NS2B/NS3 serine protease)

Beyond the preview

Go deeper on policresulen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on policresulen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call